Pancreatic cancer is a grim diagnosis, but this new study, the largest of its kind, identifies genomic markers that could increase survival by better matching chemotherapy drugs to patients.
Genomics could better match treatments to pancreatic cancer patients
Pancreatic cancer is a grim diagnosis, but this new study, the largest of its kind, identifies genomic markers that could increase survival by better matching chemotherapy drugs to patients.